Advanced search×

Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences.

Target Oncol 6(2):95-102 (2011) PMID 21499767

Integration of cellular and extracellular signals maintains tissue homeostasis under conditions of normal proliferation and stress. A central player in regulating responses to stress is the serine/threonine kinase mammalian target of rapamycin (mTOR). In many cancers, mTOR complex 1 (mTORC1) signaling is enhanced, even under conditions where such signaling should be suppressed. This article reviews some of the details that are emerging on how low oxygen (hypoxia) regulates mTORC1 signaling, and the consequences for dysregulation in pediatric solid tumors.

DOI: 10.1007/s11523-011-0173-x
Version: za2963e q8zad q8zb6 q8zc8 q8zdf q8zea q8zf8 q8zg1

Similar articles you may find interesting…

  1. [Allergen immunotherapy for allergic rhinitis.]

    Rhinology 51(2):99-110 (2013) PMID 23671890

    Allergic rhinitis, a risk factor for bronchial asthma, is a global health problem that impairs patients` physical and social activity and consequently their quality of life. Specific Immunotherapy (SIT) involves the administration, subcutaneously or sublin- gually, of increasing dose...
  2. Fluorescent optical fiber sensors for cell viability monitoring.

    Analyst (2013) PMID 23662302

    A new simple method for non-invasive cell culture viability monitoring based on vital fluorescent stains is introduced, and its efficiency for long-term experiments on cells is demonstrated. In contrast to common methods for cell viability control, which are usually either destructiv...
  3. Fracture Risk in Older, Long-Term Survivors of Early-Stage Breast Cancer.

    J Am Geriatr Soc (2013) PMID 23647433

    No difference was observed in fracture rates between groups (hazard ratio (HR) = 1.1, 95% confidence interval (CI) = 0.9-1.3). The protective effect of tamoxifen was not statistically significant (HR = 0.9, 95% CI = 0.6-1.2). CONCLUSION: Long-term survivors of early-stage breast cancer diagn...